Regis Healthcare

Regis Healthcare reported for fiscal year 2026 a 16% rise in annual revenue from services to AUD 1.35 billion, adjusted EBITDA of AUD 138 million and adjusted NPAT of AUD 55 million. Growth was driven largely by the acquisitions of Rockpool and OC Health, government indexation, higher accommodation prices and a larger share of privately paying residents. Operating net cash flow was AUD 336 million, net inflows from RADs rose 28% to AUD 250 million, leaving the year with a net cash position of AUD 174 million; the share price subsequently rose sharply. For 2027 Regis plans capex of over AUD 150 million but sees risks from wage inflation and limited occupancy upside, so future growth is expected to come more from pricing and mix. » Plus sur de.investing.com

Regis Healthcare reports service revenue of $667.7m (+18.4%) for the six months to 31 December 2025 and adjusted EBITDA of $70.6m with an EBITDA margin of 10.6%. Adjusted net profit remained largely unchanged at $29.7m, while operating cash flow rose 39.9% to $291.7m thanks to higher Refundable Accommodation Deposits (RAD) and net cash reached $198.0m. Regis announced a fully franked interim dividend of 9.0 cents per share, is growing its portfolio through acquisitions (+830 beds) and new builds, and reiterated FY2026 guidance for adjusted EBITDA of $130–135m. Management also warned of margin pressure from AN‑ACC funding reforms and integration costs. » Plus sur de.investing.com

Regis reported a 28% revenue increase to USD 59 million in Q1 2025 and adjusted EBITDA of USD 8 million. The company generated positive operating cash flow for the fourth consecutive quarter (USD 2.3 million) and expects an increase in available cash. The takeover of 281 company-owned salons strengthened its market position; Regis anticipates annual G&A costs of USD 40–43 million and plans to optimize its salon portfolio. Regis stock rose about 8% in premarket trading to USD 30.50. » Plus sur de.investing.com